Atlas Trials

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Clinical trial NCT01928186 · COMPLETED

Trial details

NCT number
NCT01928186
Sponsor
University of Washington
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Estrogen Receptor PositiveHER2/Neu NegativeMale Breast CarcinomaStage IA Breast CancerStage IB Breast CancerStage IIA Breast CancerStage IIB Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer
Start date
2011-09-01
Primary completion
2015-07-20
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.